Quarum M L, Parker J D, Keana J F, Weber E
Vollum Institute, Oregon Health Sciences University, Portland.
J Neurochem. 1990 Apr;54(4):1163-8. doi: 10.1111/j.1471-4159.1990.tb01944.x.
The pharmacological specificity and the regional distribution of the N-methyl-D-aspartate receptor-associated 5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801) binding sites in human postmortem brain tissue were determined by binding studies using (+)-[3H]MK-801. Scatchard analysis revealed a high-affinity (KD = 0.9 +/- 0.2 nM, Bmax = 499 +/- 33 fmol/mg of protein) and a low-affinity (KD = 3.6 +/- 0.9 nM, Bmax = 194 +/- 44 fmol/mg of protein) binding site. The high-affinity site showed a different regional distribution of receptor density (cortex greater than hippocampus greater than striatum) compared to the low-affinity binding site (cerebellum greater than brainstem). The rank order pharmacological specificity and stereoselectivity of the high-(cortex) and low-(cerebellar) affinity binding sites were identical. However, all compounds tested showed greater potency at the high-affinity site in cortex. The results indicate that (+)-[3H]MK-801 binding in human postmortem brain tissue shows pharmacological and regional specificity.
使用(+)-[3H]MK-801进行结合研究,测定了N-甲基-D-天冬氨酸受体相关的马来酸5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺(MK-801)结合位点在人死后脑组织中的药理学特异性和区域分布。Scatchard分析显示存在一个高亲和力结合位点(KD = 0.9 +/- 0.2 nM,Bmax = 499 +/- 33 fmol/mg蛋白质)和一个低亲和力结合位点(KD = 3.6 +/- 0.9 nM,Bmax = 194 +/- 44 fmol/mg蛋白质)。与低亲和力结合位点(小脑>脑干)相比,高亲和力位点显示出不同的受体密度区域分布(皮质>海马体>纹状体)。高亲和力(皮质)和低亲和力(小脑)结合位点的药理学特异性和立体选择性的排序相同。然而,所有测试化合物在皮质的高亲和力位点显示出更高的效力。结果表明,(+)-[3H]MK-801在人死后脑组织中的结合表现出药理学和区域特异性。